Author:
dhorai Niveditha,Manickam Paulpandi,Rangaraj Suriyaprabha,Venkatachalam Rajendran
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. M.S. Allen, G.E. Darling, T.T. Pechet et al., Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann. Thorac. Surg. 81(3), 1013–1019 (2006)
2. C.I. Amos, X. Wu, P. Broderick et al., Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. [published online ahead of print April 2, 2008]
3. S. Anjum, M. Hashim, S.A. Malik, M. Khan, J.M. Lorenzo, B.H. Abbasi, C. Hano, Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers 13(18), 4570 (2021)
4. R. Aswini, S. Murugesan, K. Kannan, Bio-engineered TiO2 nanoparticles using Ledebouria revoluta extract: larvicidal, histopathological, antibacterial and anticancer activity. Int. J. Environ. Anal. Chem. 101, 2926–2936 (2021)
5. J.E. Bailey-Wilson, C.I. Amos, S.M. Pinney et al., A major lung cancer susceptibility locus maps to chromosome 6p23–25. Am. J. Human Genet. 75(3), 460–474 (2004). (Epub 2004 Jul 21)